DJIA 18,235.55 -50.19 -0.27%
NASDAQ 5,092.95 2.15 0.04%
S&P 500 2,128.47 -2.35 -0.11%
market minute promo

20.30 -0.32 (-1.55%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AEGR $20.30 -1.55%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $20.55
Previous Close $20.62
Daily Range $20.20 - $20.80
52-Week Range $19.10 - $36.68
Market Cap $580.0M
P/E Ratio -15.16
Dividend (Yield) $0.00 (0.0%)
Volume 219,207
Average Daily Volume 643,804
Current FY EPS -$1.27

Sector

Healthcare

Industry

Drug Makers

Aegerion Pharmaceuticals, Inc. (AEGR) Description

Aegerion Pharmaceuticals, Inc. Website: http://www.aegerion.com/

News & Commentary Rss Feed

Is This The Biggest Threat to Isis Pharmaceuticals Stock?

Isis Pharmaceuticals has garnered a massive premium based on the potential of its antisense drug pipeline. With numerous companies entering the rare disease field, though, Isis' drugs might face stiff competition. So are investors being overly optimistic?

Keryx Biopharmaceuticals: Watch For An FDA Warning Letter

Aegerion's Q1 Loss Narrower than Expected, View Retained - Analyst Blog

Aegerion Pharmaceuticals' (AEGR) CEO Marc Beer on Q1 2015 Results - Earnings Call Transcript

Aegerion Pharmaceuticals (AEGR) Q1 2015 Results - Earnings Call Webcast

Earnings Reaction History: Aegerion Pharmaceuticals, Inc., 57.1% Follow-Through Indicator, 10.2% Sen

Earnings Reaction History: Aegerion Pharmaceuticals, Inc., 57.1% Follow-Through Indicator, 10.2% Sensitive

What is in Store for Aegerion (AEGR) This Earnings Season? - Analyst Blog

Why It’s Not Too Late to Buy Isis Pharmaceuticals Stock

Isis Pharmaceuticals has had an enormous run of late. Is this drugmaker still a buy?

Aegerion Pharmaceuticals Expects Little Growth In 2015

Aegerion's Q4 Loss Narrows Y/Y, Ups Juxtapid Sales View - Analyst Blog

See More AEGR News...

AEGR's Top Competitors

AEGR $20.30 (-1.55%)
Current stock: AEGR
JNJ $101.67 (-0.73%)
Current stock: JNJ
NVS $104.03 (-0.73%)
Current stock: NVS
RHHBY $36.84 (-0.91%)
Current stock: RHHBY